• Search chemicals, activators, Inhibitors, APIs, intermediates and raw materials.


(CAS: 905723-46-8 )

Suppliers of MK-2305

Company Name Email Tel Country
AMEDCHEM [email protected] +862168061059 CHINA

Fax: Purity: Brand:

Inquiry Online

Salutation: *Country:
*Customer: *Company Name:
*Email: *Request quantity:

Notice: Your contact information will be sent to selected suppliers.

* Required Fields.

Background Information of MK-2305

MK-2305 is a non-carboxylate GPR40 agonist. GPR40, also known as FFAR1, belongs to the class A family of G-protein coupled receptors, and is expressed predominantly in pancreatic β cells and enteroendocrine cells.GPR40 partial agonism is a promising new mechanism for the treatment of type 2 diabetes mellitus with clinical proof of concept. 

Solubility of MK-2305

Solubility Sources

Storage Condition of MK-2305

Storage Condition Sources

MSDS Information

MSDS Sources

Quality Control and Spectral Data

QC Reports Sources

Mechanism and Indications

Signaling Pathways GPCR/G Protein
Target GPR40
Research Area Metabolic Disease

Clinical Information

Product Name Sponsor & Collaborators Indications Start Date End Date Phase

Chemical Information

M.Wt Formula CAS No. Synonyms
443.82 C19H13ClF3NO4S 905723-46-8

Structure Information of MK-2305

Smiles C1C(C(F)(F)F)=CC(Cl)=C(OC2=CC3OCC[[email protected]](C4SC(=O)NC4=O)([H])C=3C=C2)C=1 |&1:17|
InChI InChI=1S/C19H13ClF3NO4S/c20-13-7-9(19(21,22)23)1-4-14(13)28-10-2-3-11-12(5-6-27-15(11)8-10)16-17(25)24-18(26)29-16/h1-4,7-8,12,16H,5-6H2,(H,24,25,26)/t12-,16?/m1/s1

Related Products

Other Form Products of MK-2305

Name CAS Formula Suppliers

Recommended Products in Same Target

Name CAS Formula Suppliers
AMG 837 (calcium hydrate) 1259389-38-2 C26H22F3O4- 9
AMG 837 (sodium salt) 865231-45-4 C26H20F3NaO3 6
GPR40 Activator 1 1309435-60-6 C31H31NO3S 6
AMG 837 865231-46-5 C26H21F3O3 12
TUG-770 1402601-82-4 C19H14FNO2 13
GW9508 885101-89-3 C22H21NO3 22
TAK-875 1000413-72-8 C29H32O7S 16
GW-1100 306974-70-9 C27H25FN4O4S 9
GPR40 Activator 2 1312787-30-6 C28H29NO6S2 6
DC260126 346692-04-4 C32H31N5O 7
M-I C19H22O5S 0
T-1676427 1000414-39-0 C29H32O8S 0
JTT-851 C23H28O3 0
Astellas C27H30N4O4 0
Mochida 1469495-84-8 C30H35NO6S 0
BMS-986118 1610562-74-7 C25H28ClF3N4O4 2
AM-6226 C32H36F2O4 0
GPR40 agonist 1 1312788-44-5 C24H20O3 0
GPR40 agonist 2 C25H22O3 0
GPR40 agonist 3 C23H18O3 0

Recommended Products in the Same Indication

Name CAS Formula Suppliers

Chemical and Physical Properties

Appearance: Melting point:
Boiling point: Flash Point:
Water Solubility: Solubility:
Density: Merck:
BRN: Refractive Index:
Vapour: EINECS:
Optical Rotation: alpha:


[1].Huang H, et al. Discovery of novel benzo[b]thiophene tetrazoles as non-carboxylate GPR40 agonists. Bioorg Med Chem Lett. 2017 Dec 12. pii: S0960-894X(17)31182-4.
GPR40 partial agonism is a promising new mechanism for the treatment of type 2 diabetes mellitus with clinical proof of concept. Most of the GPR40 agonists in the literature have a carboxylic acid functional group, which may pose a risk for idiosyncratic drug toxicity. A novel series of GPR40 agonists containing a tetrazole as a carboxylic acid bioisostere was identified. This series of compounds features a benzo[b]thiophene as the center ring, which is prone to oxidation during phase 1 metabolism. Following SAR optimization targeting GPR40 agonist activity and intrinsic clearance in microsomes (human and rat), potent and metabolically stable compounds were selected for in vivo evaluation. The compounds are efficacious at lowering blood glucose in a SD rat oGTT model.

Tags: buy MK-2305 | MK-2305 IC50 | MK-2305 price | MK-2305 cost | MK-2305 solubility | MK-2305 purchase | MK-2305 manufacturer | MK-2305 research buy | MK-2305 order | MK-2305 MSDS | MK-2305 chemical structure | MK-2305 Storage condition | MK-2305 molecular weight | MK-2305 mw | MK-2305 datasheet | MK-2305 supplier | MK-2305 cell line | MK-2305 NMR | MK-2305 MS | MK-2305 IR | MK-2305 solubility | MK-2305 Safe information | MK-2305 Qc and Spectral Information | MK-2305 Clinical Information | MK-2305 Clinical Trial | MK-2305 Route of Synthesis | MK-2305 storage condition | MK-2305 diseases and conditions | MK-2305 flash point | MK-2305 boiling point | MK-2305 melting point | MK-2305 storage condition | MK-2305 brand